Regeneron is a biotechnology company that develops and commercializes medicines for the treatment of metabolic, inflammatory and infectious diseases.
Business Model:
Revenue: $12.2B
Employees: 10,001-999,999
Address: 777 Old Saw Mill River Road
City: Tarrytown
State: NY
Zip: 10591
Country: US
Regeneron is a biotechnology company that develops and commercializes medicines for the treatment of metabolic, inflammatory and infectious diseases.
Contact Phone:
+19148477000
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/12/1991
Ticker Symbol:
REGN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2019 | Alnylam Pharmaceuticals | Post-IPO Equity | 0 |
5/2022 | Vyriad | Series B | 0 |
1/2023 | 2seventy bio | Post-IPO Equity | 20M |
6/2020 | DNAnexus | Series G | 0 |
6/2018 | Decibel Therapeutics | Series C | 55M |
9/2019 | Adicet Bio | Series B | 0 |
5/2022 | Vyriad | Series B | 0 |
6/2020 | DNAnexus | Series G | 0 |
9/2019 | Adicet Bio | Series B | 0 |
4/2019 | Alnylam Pharmaceuticals | Post-IPO Equity | 0 |
6/2018 | Decibel Therapeutics | Series C | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2016 | Post-IPO Equity | 1 | $8.9M |
U.S. Department of Health &a; Human Services U.S. Department of Health &a; Human Services U.S. Department of Health &a; Human Services U.S. Department of Health &a; Human Services |
6/1988 | Angel | $1M | 1/1991 | IPO | $91.6M | 8/2020 | Post-IPO Debt | $2B |
---|
Announced Date | Name | Price |
---|---|---|
4/2022 | Checkmate Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|